Notice2025-03639

Hexamethylenetetramine From the People's Republic of China: Preliminary Affirmative Countervailing Duty Determination and Alignment of Final Determination With Final Antidumping Duty Determination

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
March 7, 2025

Issuing agencies

Commerce DepartmentInternational Trade Administration

Abstract

The U.S. Department of Commerce (Commerce) preliminarily determines that countervailable subsidies are being provided to producers and exporters of hexamethylenetetramine (hexamine) from the People's Republic of China (China). The period of investigation is January 1, 2023, through December 31, 2023. Interested parties are invited to comment on this preliminary determination.

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 44 (Friday, March 7, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 44 (Friday, March 7, 2025)]
[Notices]
[Pages 11508-11510]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-03639]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

International Trade Administration

[C-570-181]


Hexamethylenetetramine From the People's Republic of China: 
Preliminary Affirmative Countervailing Duty Determination and Alignment 
of Final Determination With Final Antidumping Duty Determination

AGENCY: Enforcement and Compliance, International Trade Administration, 
Department of Commerce.

SUMMARY: The U.S. Department of Commerce (Commerce) preliminarily 
determines that countervailable subsidies are being provided to 
producers and exporters of hexamethylenetetramine (hexamine) from the 
People's Republic of China (China). The period of investigation is 
January 1, 2023, through December 31, 2023. Interested parties are 
invited to comment on this preliminary determination.

DATES: Applicable March 7, 2025.

FOR FURTHER INFORMATION CONTACT: Eliza DeLong, AD/CVD Operations, 
Office V, Enforcement and Compliance, International Trade 
Administration, U.S. Department of Commerce, 1401 Constitution Avenue 
NW, Washington, DC 20230; telephone: (202) 482-3878.

SUPPLEMENTARY INFORMATION:

Background

    This preliminary determination is made in accordance with section 
703(b) of the Tariff Act of 1930, as amended (the Act). On November 4, 
2024, Commerce published the notice of initiation of this 
countervailing duty (CVD) investigation in the Federal Register.\1\ On 
November 21, 2024, Commerce postponed the preliminary determination 
until February 28, 2025.\2\
---------------------------------------------------------------------------

    \1\ See Hexamethylenetetramine from the People's Republic of 
China and India: Initiation of Countervailing Duty Investigations, 
89 FR 87560 (November 4, 2024) (Initiation Notice).
    \2\ See Hexamethylenetetramine from the People's Republic of 
China and India: Postponement of the Preliminary Determinations in 
the Countervailing Duty Investigations, 89 FR 92096 (November 21, 
2024).
---------------------------------------------------------------------------

    For a complete description of the events that followed the 
initiation of this investigation, see the Preliminary Decision 
Memorandum.\3\ A list of topics discussed in the Preliminary Decision 
Memorandum is included as Appendix II to this notice. The Preliminary 
Decision Memorandum is a public document and is on file electronically 
via Enforcement and Compliance's Antidumping and Countervailing Duty 
Centralized Electronic Service System (ACCESS). ACCESS is available to 
registered users at <a href="https://access.trade.gov">https://access.trade.gov</a>. In addition, a complete 
version of the Preliminary Decision Memorandum can be accessed directly 
at <a href="https://access.trade.gov/public/FRNoticesListLayout.aspx">https://access.trade.gov/public/FRNoticesListLayout.aspx</a>.
---------------------------------------------------------------------------

    \3\ See Memorandum, ``Decision Memorandum for the Preliminary 
Determination in the Countervailing Duty Investigation of 
Hexamethylenetetramine from the People's Republic of China,'' dated 
concurrently with, and hereby adopted by, this notice (Preliminary 
Decision Memorandum).
---------------------------------------------------------------------------

Scope of the Investigation

    The product covered by this investigation is hexamine from China. 
For a complete description of the scope of this investigation, see 
Appendix I.

Scope Comments

    In accordance with the Preamble to Commerce's regulations,\4\ the 
Initiation Notice set aside a period of time for parties to raise 
issues regarding product coverage (i.e., scope).\5\ No interested

[[Page 11509]]

parties commented on the scope of the investigation as it appeared in 
the Initiation Notice.
---------------------------------------------------------------------------

    \4\ See Antidumping Duties; Countervailing Duties; Final Rule, 
62 FR 27296, 27323 (May 19, 1997) (Preamble).
    \5\ See Initiation Notice.
---------------------------------------------------------------------------

Methodology

    Commerce is conducting this investigation in accordance with 
section 701 of the Act. For each of the subsidy programs found 
countervailable, Commerce preliminarily determines that there is a 
subsidy, i.e., a financial contribution by an ``authority'' that gives 
rise to a benefit to the recipient, and that the subsidy is 
specific.\6\ For a full description of the methodology underlying our 
preliminary determination, see the Preliminary Decision Memorandum.
---------------------------------------------------------------------------

    \6\ See sections 771(5)(B) and (D) of the Act regarding 
financial contribution; section 771(5)(E) of the Act regarding 
benefit; and section 771(5A) of the Act regarding specificity.
---------------------------------------------------------------------------

    Commerce notes that, in making these findings, we relied on facts 
available and, because we find that one or more respondents did not act 
to the best of their ability to respond to Commerce's requests for 
information, we drew an adverse inference where appropriate in 
selecting from among the facts otherwise available.\7\ For further 
information, see ``Use of Facts Otherwise Available and Adverse 
Inferences'' section in the Preliminary Decision Memorandum.
---------------------------------------------------------------------------

    \7\ See sections 776(a) and (b) of the Act.
---------------------------------------------------------------------------

Alignment

    In accordance with section 705(a)(1) of the Act and 19 CFR 
351.210(b)(4), Commerce is aligning the final CVD determination in this 
investigation with the final determination in the companion 
investigation of sales at less than fair value (LTFV) of hexamine from 
China based on a request made by the petitioner.\8\ Consequently, the 
final CVD determination will be issued on the same date as the final 
LTFV determination, which is currently scheduled to be issued no later 
July 14, 2025, unless postponed.\9\
---------------------------------------------------------------------------

    \8\ See Petitioner's Letter, ``Request for Alignment of Final 
Determinations with Deadline in Concurrent AD Investigations,'' 
dated January 23, 2025.
    \9\ See Hexamethylenetetramine from the People's Republic of 
China, Germany, India, and Saudi Arabia: Postponement of Preliminary 
Determinations in the Less-Than-Fair-Value Investigations, 90 FR 
10067 (February 21, 2025).
---------------------------------------------------------------------------

All-Others Rate

    Sections 703(d) and 705(c)(5)(A) of the Act provide that in the 
preliminary determination, Commerce shall determine an estimated all-
others rate for companies not individually examined. This rate shall be 
an amount equal to the weighted average of the estimated subsidy rates 
established for those companies individually examined, excluding any 
zero and de minimis rates and any rates based entirely under section 
776 of the Act.
    Pursuant to section 705(c)(5)(A)(ii) of the Act, if the individual 
estimated countervailable subsidy rates established for all exporters 
and producers individually examined are zero, de minimis, or determined 
based entirely on adverse facts available (AFA), Commerce may use ``any 
reasonable method'' to establish the estimated subsidy rate for all 
other producers or exporters. In this investigation, all rates are 
based entirely on AFA under section 776 of the Act. This is the only 
rate available in this proceeding for deriving the all-others rate. 
Consequently, pursuant to sections 703(d) and 705(c)(5)(A)(ii) of the 
Act, Commerce established the all-others rate by applying the 
countervailable subsidy rate assigned to the non-responsive companies 
listed below.

Preliminary Determination

    Commerce preliminarily determines that the following estimated 
countervailable subsidy rates exist:

------------------------------------------------------------------------
                                                           Subsidy rate
                         Company                            (percent ad
                                                             valorem)
------------------------------------------------------------------------
Changzhou Highassay Chemical Co.........................        * 420.53
China Bluestar International Chemical Co., Ltd..........        * 420.53
Fengchen Group Co., Ltd.................................        * 420.53
Hutubi Ruiyuantong Chemicals Co., Ltd...................        * 420.53
Jiangsu Guotai Guomian Trading..........................        * 420.53
Jiaozuo Runhua Chemical Industry Co.....................        * 420.53
Qingdao Sun Chemical Corp. Ltd..........................        * 420.53
Runhua Chemical Industry................................        * 420.53
Shandong Aojin Chemical Technology Co., Ltd.............        * 420.53
All Others..............................................          420.53
------------------------------------------------------------------------
* Rate based on facts available with adverse inferences.

Suspension of Liquidation

    In accordance with section 703(d)(1)(B) and (d)(2) of the Act, 
Commerce will direct U.S. Customs and Border Protection (CBP) to 
suspend liquidation of entries of subject merchandise as described in 
the scope of the investigation entered, or withdrawn from warehouse, 
for consumption on or after the date of publication of this notice in 
the Federal Register. Further, pursuant to 19 CFR 351.205(d), Commerce 
will instruct CBP to require a cash deposit equal to the rates 
indicated above.

Disclosure

    Normally, Commerce discloses its calculations performed in 
connection with the preliminary determination to interested parties 
within five days of its public announcement, or if there is no public 
announcement, within five days of the date of publication of the 
notice, in accordance with 19 CFR 351.224(b). However, because Commerce 
preliminarily applied facts available with adverse inferences in the 
calculation of the benefit for the non-responsive companies, and the 
applied AFA rates are based on rates calculated in prior proceedings, 
there are no calculations to disclose.

Verification

    Because the non-responsive companies did not participate in this 
investigation and because the Government of China did not provide 
information Commerce requested, Commerce preliminarily determines each 
of these parties to have been uncooperative and it will not conduct 
verification.

Public Comment

    Case briefs or other written comments may be submitted to the 
Assistant Secretary for Enforcement and Compliance no later than 30 
days after the date of publication of the preliminary determination. 
Rebuttal briefs, limited to issues raised in the case briefs, may be 
filed not later than five days after the date for filing case 
briefs.\10\ Interested parties who submit case briefs or rebuttal 
briefs in this proceeding must submit: (1) a table of contents listing 
each issue; and (2) a table of authorities.\11\
---------------------------------------------------------------------------

    \10\ See 19 CFR 351.309(d); see also Administrative Protective 
Order, Service, and Other Procedures in Antidumping and 
Countervailing Duty Proceedings, 88 FR 67069, 67077 (September 29, 
2023) (APO and Service Final Rule).
    \11\ See 19 CFR 351.309(c)(2) and (d)(2).
---------------------------------------------------------------------------

    As provided under 19 CFR 351.309(c)(2) and (d)(2), in prior 
proceedings we have encouraged interested parties to provide an 
executive summary of their brief that should be limited to five pages 
total, including footnotes. In this investigation, we instead request 
that interested parties provide at the beginning of their briefs a 
public executive summary for each issue raised in their briefs.\12\ 
Further, we request that interested parties limit their public 
executive summary of each issue to no more than 450 words, not 
including

[[Page 11510]]

citations. We intend to use the public executive summaries as the basis 
of the comment summaries included in the issues and decision memorandum 
that will accompany the final determination in this investigation. We 
request that interested parties include footnotes for relevant 
citations in the executive summary of each issue. Note that Commerce 
has amended certain of its requirements pertaining to the service of 
documents in 19 CFR 351.303(f).\13\
---------------------------------------------------------------------------

    \12\ We use the term ``issue'' here to describe an argument that 
Commerce would normally address in a comment of the Issues and 
Decision Memorandum.
    \13\ See APO and Service Final Rule.
---------------------------------------------------------------------------

    Pursuant to 19 CFR 351.310(c), interested parties who wish to 
request a hearing, limited to issues raised in the case and rebuttal 
briefs, must submit a written request to the Assistant Secretary for 
Enforcement and Compliance, U.S. Department of Commerce via ACCESS 
within 30 days after the date of publication of this notice. Requests 
should contain the party's name, address, and telephone number, the 
number of participants and whether any participant is a foreign 
national, and a list of the issues to be discussed. Oral presentations 
at the hearing will be limited to issues raised in the briefs. If a 
request for a hearing is made, Commerce intends to hold the hearing at 
a time and date to be determined.\14\ Parties should confirm by 
telephone the date, time, and location of the hearing two days before 
the scheduled date.
---------------------------------------------------------------------------

    \14\ See 19 CFR 351.310(d).
---------------------------------------------------------------------------

U.S. International Trade Commission (ITC) Notification

    In accordance with section 703(f) of the Act, Commerce will notify 
the ITC of its determination. If the final determination is 
affirmative, the ITC will determine before the later of 120 days after 
the date of this preliminary determination or 45 days after the final 
determination whether imports of hexamine from China are materially 
injuring, or threaten material injury to, the U.S. industry.

Notification to Interested Parties

    This determination is issued and published pursuant to sections 
703(f) and 777(i)(1) of the Act and 19 CFR 351.205(c).

    Dated: February 28, 2025.
Christopher Abbott,
Deputy Assistant Secretary for Policy and Negotiations, performing the 
non-exclusive functions and duties of the Assistant Secretary for 
Enforcement and Compliance.

Appendix I

Scope of the Investigation

    The scope of this investigation covers hexamine in granular 
form, with a particle size of 5 millimeters or less, whether 
stabilized or unstabilized, whether or not blended, mixed, 
pulverized, or grounded with other products, containing 50 percent 
or more hexamine by weight.
    Hexamine is the common name for hexamethylene tetramine 
(Chemical Abstract Service #100-97-0), and is also referred to as 
1,3,5,7-tetraazaadamantanemethenamine; HMT; HMTA; 1,3,5,7-
tetraazatricyclo {3.3.1.13,7{time}  decane; 1,3,5,7-tetraaza 
adamantane; hexamethylenamine. Hexamine has the chemical formula C6 
H12 N4.
    Granular hexamine that has been blended with other product(s) is 
included in this scope when the resulting mix contains 50 percent or 
more of hexamine by weight, regardless of whether it is blended with 
inert additives, co-reactants, or any additives that undergo self-
condensation.
    Subject merchandise includes merchandise matching the above 
description that has been processed in a third country, including by 
commingling, diluting, adding or removing additives, or performing 
any other processing that would not otherwise remove the merchandise 
from the scope of the investigation if performed in the subject 
country.
    Merchandise covered by the scope of this investigation can be 
classified in the Harmonized Tariff Schedule (HTSUS) of the United 
States under the subheading 2933.69.5000. The HTSUS subheading and 
Chemical Abstracts Service registry number are provided for 
convenience and customs purposes only; however, the written 
description of the scope is dispositive.

Appendix II

List of Topics Discussed in the Preliminary Decision Memorandum

I. Summary
II. Background
III. Injury Test
IV. Diversification of China's Economy
V. Analysis of China's Financial System
VI. Use of Facts Otherwise Available and Adverse Inferences
VII. Recommendation

[FR Doc. 2025-03639 Filed 3-6-25; 8:45 am]
BILLING CODE 3510-DS-P


</pre></body>
</html>
Indexed from Federal Register on March 7, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.